Cisplatin and gemcitabine (GC) as neoadjuvant therapy of stage III unresectable non-small cell lung cancer (NSCLC):: A phase II study

被引：0
|
作者：
Mazzoni, F
Di Stefano, A
Maestri, A
Calandri, C
Mosconi, AM
De Marinis, F
Scagliotti, GV
Selvaggi, G
Crinò, L
Tonato, M
机构：
[1] Monteluce Policlin, UO Med Oncol, Bologna, Italy
[2] Osped Forlanini, Rome, Italy
[3] Univ Turin, Dipartimento Sci Biomed, I-10124 Turin, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A32
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine and cisplatin (GC) as neoadjuvant chemotherapy in unresectable stage III non-small cell lung cancer (NSCLC).
    Crino, L
    Mazzoni, F
    Maestri, A
    Calandri, C
    Selvaggi, G
    Scagliotti, GV
    De Marinis, F
    Gregorc, V
    Darwish, S
    Tonato, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 108 - 108
  • [2] A phase II study of neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage III unresectable non-small cell lung cancer
    Iacobelli, S
    Irtelli, L
    Sacco, R
    Martino, M
    Mascitelli, E
    Basilico, L
    Scognamiglio, M
    Natoli, C
    Fusco, O
    Tinari, N
    Beltrami, V
    [J]. ANTICANCER RESEARCH, 1998, 18 (3B) : 2081 - 2084
  • [3] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [4] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [5] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [6] Gemcitabine and Cisplatin Followed by Concurrent Gemcitabine and Radiotherapy or Sequential Radiotherapy Alone in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
    Kerner, G. S. M. A.
    van Dullemen, L. F. A.
    Wiegman, E. M.
    van der Leest, A. H. D.
    Widder, J.
    Ubbels, J. F.
    Hiltermann, T. J. N.
    Groen, H. J. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S600 - S600
  • [7] Phase II multicentric study of concurrent chemoradiation i with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung cancer (NSCLC).
    Blanco, R
    Solé, J
    Nogué, M
    Montesinos, J
    Gallardo, E
    Vadell, C
    Mesía, C
    Algara, M
    Terrassa, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 696S - 696S
  • [8] Paclitaxel, cisplatin and gemcitabine combination chemotherapy in stage IV non-small cell lung cancer (NSCLC):: A phase II study.
    Cortes, J
    Rodriguez, J
    Calvo, E
    Martinez-Monge, R
    Fernández-Hildago, O
    Garzón, C
    Santisteban, M
    de Irala, J
    Azinovic, I
    Brugarolas, A
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [9] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
  • [10] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
12345